APA (7th ed.) Citation

RA, G., WR, J., RL, K., N, J., SJ, C., D, B., . . . PS, K. (2025). Liver-directed AAV gene therapy in mice corrects glycogen storage disease type IX γ2. Science advances, 11(46), eady6760. https://doi.org/10.1126/sciadv.ady6760

Chicago Style (17th ed.) Citation

RA, Gibson, et al. "Liver-directed AAV Gene Therapy in Mice Corrects Glycogen Storage Disease Type IX γ2." Science Advances 11, no. 46 (2025): eady6760. https://doi.org/10.1126/sciadv.ady6760.

MLA (9th ed.) Citation

RA, Gibson, et al. "Liver-directed AAV Gene Therapy in Mice Corrects Glycogen Storage Disease Type IX γ2." Science Advances, vol. 11, no. 46, 2025, p. eady6760, https://doi.org/10.1126/sciadv.ady6760.